🇺🇸 FDA
Pipeline program

FLUOROURACIL, DOCETAXEL, OPDIVO 10 mg/mL concentrate for solution for infusion., OXALIPLATIN, CALCIUM LEVOFOLINATE, CISPLATIN, DOXORUBICIN HYDROCHLORIDE

PIPAC_VEROne

Phase 3 small_molecule active

Quick answer

FLUOROURACIL, DOCETAXEL, OPDIVO 10 mg/mL concentrate for solution for infusion., OXALIPLATIN, CALCIUM LEVOFOLINATE, CISPLATIN, DOXORUBICIN HYDROCHLORIDE for Gastric adenocarcinoma with peritoneal metastases is a Phase 3 program (small_molecule) at Verona Pharma Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Verona Pharma Ireland Limited
Indication
Gastric adenocarcinoma with peritoneal metastases
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials